Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

By Wahlander K.   Lapidus L.   Olsson C.-G.   Thuresson A.   Eriksson U.G.   Larson G.   Eriksson H.  

Thrombosis Research, Vol. 107, Iss. 3, 2002-08 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

An update on the Management and Treatment of Deep Vein Thrombosis

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 4, 2011-10 ,pp. : 207-217

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of the Clinical Uses of Ximelagatran in Thrombosis Syndromes

By Bergsrud Elizabeth A.   Gandhi Pritesh J.  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 3, 2003-12 ,pp. : 175-188

Springer Publishing Company

Access to resources Recommend Favorite

Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis

By Kearon C.   Harrison L.   Crowther M.   Ginsberg J.S.  

Thrombosis Research, Vol. 97, Iss. 6, 2000-03 ,pp. : 395-403

Elsevier

Access to resources Recommend Favorite

Idiopathic pulmonary vein thrombosis?

By  

Respirology Case Reports, Vol. 6, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite